| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 05/01/2013 | EP2585440A1 3-amino-5,6-dihydro-1h-pyrazin-2-one derivatives useful for the treatement of alzheimer's disease and other forms of dementia |
| 05/01/2013 | EP2585439A1 Heterocyclic compounds, their preparation and their therapeutic application |
| 05/01/2013 | EP2585437A2 Thioacetate compounds, compositions and methods of use |
| 05/01/2013 | EP2585066A2 Prodrugs of nh-acidic compounds: ester, carbonate, carbamate and phosphonate derivatives |
| 05/01/2013 | EP2318390B1 Pyrrole compounds |
| 05/01/2013 | CN103080109A Deuterium-enriched heterocyclic compounds as kinase inhibitors |
| 05/01/2013 | CN103080102A Anthranilic acid diamide derivative as a pesticide |
| 05/01/2013 | CN103080101A Piperidinyl-substituted lactams as GPR119 modulators |
| 05/01/2013 | CN103080100A Method for producing 1-triazole-2-butanol derivative |
| 05/01/2013 | CN103080093A Indazole compounds and their uses |
| 05/01/2013 | CN103080087A Piperidine derivatives and their use for the treatment of metabolic disorders |
| 05/01/2013 | CN103080086A Prostaglandin D synthase inhibitory piperidine compounds |
| 05/01/2013 | CN103079406A Fungicidal pyrazoles |
| 05/01/2013 | CN103073539A 4-(substituted phenylamino)quinazoline derivative, and preparation method, pharmaceutical composition and application thereof |
| 05/01/2013 | CN103073536A Preparation method of ilaprazole |
| 05/01/2013 | CN103073535A Synthetic method of imidacloprid |
| 05/01/2013 | CN102250066B Fasudil derivative and preparation method thereof |
| 05/01/2013 | CN101921261B Separation and recovery process after imidacloprid synthesis |
| 05/01/2013 | CN101821246B Tetrazole-substituted aryl amide derivatives and uses thereof |
| 05/01/2013 | CN101735199B O-formamidebenzoyl-pyrazole compound as well as preparation method and application thereof |
| 05/01/2013 | CN101723935B 1,5-diaryl-substituted 2,4-dienone derivative as well as preparation method and application thereof |
| 05/01/2013 | CN101679270B Dihydroquinone and dihydronaphthridine inhibitors of JNK |
| 05/01/2013 | CN101657430B Organic compounds and their uses |
| 05/01/2013 | CN101558057B 2 -alkyl- indazole compounds for the treatment of certain cns-related disorders |
| 05/01/2013 | CN101558056B Process for production of anthranilamide compound |
| 05/01/2013 | CN101495469B N-(aminoheteroaryl)-1H-indole-2-carboxamide derivatives as antagonist of TRPV1 or VR1 receptor, preparation thereof and therapeutic use thereof |
| 05/01/2013 | CN101479255B C-MET protein kinase inhibitors for the treatment of proliferative disorders |
| 05/01/2013 | CN101323609B Method for synthesizing high antipode content benzimidazole derivative by unsymmetrical oxidizing thioether into sulphoxide |
| 04/30/2013 | USRE44186 Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method |
| 04/30/2013 | US8431712 Methods for the synthesis of pyridoxamine |
| 04/30/2013 | US8431711 Organic compound |
| 04/30/2013 | US8431700 Alkylsulfonyl-2,3-dihydrospiro[indene-1,4′-piperidine] analogs as GlyT1 inhibitors, methods for making same, and use of same in treating psychiatric disorders |
| 04/30/2013 | US8431607 Compounds and compositions as inhibitors of cannabinoid receptor 1 activity |
| 04/30/2013 | US8431606 Medicament for treating schizophrenia comprising cilostazol |
| 04/30/2013 | US8431598 Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione |
| 04/30/2013 | US8431597 Benzimidazole derivatives |
| 04/30/2013 | US8431590 Spiroindolines as modulators of chemokine receptors |
| 04/30/2013 | US8431589 2,4-diaminopyrimidine derivatives |
| 04/30/2013 | US8431578 Organic compounds |
| 04/30/2013 | US8431574 Heterocyclic inhibitors of MEK and methods of use thereof |
| 04/30/2013 | US8431573 Cyanopyrimidinones |
| 04/30/2013 | US8431567 Substituted oxindole derivatives and their use as vasopressin and/or oxytocin receptor ligands |
| 04/30/2013 | US8431563 Compounds that interact with glucokinase regulatory protein for the treatment of diabetes |
| 04/30/2013 | CA2696948C 1',3'-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2h,1'h-[1,4']bipyridinyl-2'-ones |
| 04/30/2013 | CA2673249C 4,5-ring annulated indole derivatives for treating or preventing of hcv and related viral infections |
| 04/30/2013 | CA2595834C Pyrazolylaminopyridine derivatives useful as kinase inhibitors |
| 04/30/2013 | CA2517256C Aminoheteroaryl compounds as protein kinase inhibitors |
| 04/30/2013 | CA2431483C Antiviral agents |
| 04/25/2013 | WO2013059666A1 Compounds that modulate intracellular calcium |
| 04/25/2013 | WO2013059222A1 2-pyridyloxy-4-nitrile orexin receptor antagonists |
| 04/25/2013 | WO2013058643A1 Use of derivatives of betanidine and isobetanidine for the preparation of a drug for the treatment of prediabetes and diabetes |
| 04/25/2013 | WO2013058642A1 Use of betaxanthins and derivatives thereof for the preparation of a drug for the treatment of prediabetes and diabetes |
| 04/25/2013 | WO2013058343A1 Organic electroluminescence element and material for organic electroluminescence element |
| 04/25/2013 | WO2013058258A1 Bicyclic heterocyclic compound |
| 04/25/2013 | WO2013058256A1 Nitrogenated heterocyclic compound, and bactericidal agent for agricultural and horticultural purposes |
| 04/25/2013 | WO2013057711A1 Quinazoline derivatives as pi3k modulators |
| 04/25/2013 | WO2013057320A1 (hetero)aryl cyclopropylamine compounds as lsd1 inhibitors |
| 04/25/2013 | WO2013057251A2 Heteroaryl hydroxamic acid derivatives and their use in the treatment, amelioration or prevention of a viral disease |
| 04/25/2013 | WO2013057124A1 Solid forms of 1,l-dioxo-4-thiomorpholinyl)-[6-[[3(4-fluorophenyl)-5-methyl-4-isoxazolyl]methoxy]-3-pyridinyl]-methanone |
| 04/25/2013 | WO2013057013A2 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors |
| 04/25/2013 | WO2013056684A2 Thiazole derivative as dhodh inhibitor and use thereof |
| 04/25/2013 | WO2013056547A1 Synthesis of a group of hydantoin derivatives and use thereof |
| 04/25/2013 | WO2013030218A4 Selective and reversible inhibitors of ubiquitin specific protease 7 |
| 04/25/2013 | WO2013012485A3 Novel crystalline forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione |
| 04/25/2013 | WO2013005168A3 Cannabinoid receptor modulators |
| 04/25/2013 | WO2012177603A3 Metalloenzyme inhibitor compounds |
| 04/25/2013 | WO2012174164A3 Agonists of gpr131 and uses thereof |
| 04/25/2013 | WO2012122340A8 Soluble guanylate cyclase activators |
| 04/25/2013 | US20130102787 Novel indazole derivative or salt thereof and production intermediate thereof, and antioxidant using same, and use of indazole derivative or salt thereof |
| 04/25/2013 | US20130102786 Process for the preparation of 5-substituted 1-alkyltetrazolyl oxime derivatives |
| 04/25/2013 | US20130102785 Method of making coupled heteroaryl compounds via rearrangement of halogenated heteroaromatics followed by oxidative coupling |
| 04/25/2013 | US20130102781 Methods of making cocrystals |
| 04/25/2013 | US20130102636 5-Lipoxygenase-Activating Protein (FLAP) Inhibitors |
| 04/25/2013 | US20130102632 Substituted heterocyclic compounds as ion channel modulators |
| 04/25/2013 | US20130102631 Novel microbiocidal dioxime ether derivatives |
| 04/25/2013 | US20130102627 Acridines As Inhibitors Of Haspin And DYRK Kinases |
| 04/25/2013 | US20130102619 2-pyridyloxy-4-nitrile orexin receptor antagonists |
| 04/25/2013 | US20130102618 3-amino-5,6-dihydro-1h-pyrazin-2-one derivatives useful for the treatment of alzheimer's disease and other forms of dementia |
| 04/25/2013 | US20130102608 Bipyridyl derivatives |
| 04/25/2013 | US20130102607 Ureido-pyrazole derivatives for use in the treatment of rhinovirus infections |
| 04/25/2013 | US20130102604 Novel cyclopropane indolinone derivatives |
| 04/25/2013 | US20130102602 2-Aryl-4-Quinazolinones And Their Pharmaceutical Compositions |
| 04/25/2013 | US20130102600 Heteroaryl hydroxamic acid derivatives and their use in the treatment, amelioration or prevention of a viral disease |
| 04/25/2013 | US20130102598 Indenoquinolone compound, preparation method and use thereof |
| 04/25/2013 | US20130102597 Compounds and methods for treating inflammatory and fibrotic disorders |
| 04/25/2013 | US20130102592 Oxazole tyrosine kinase inhibitors |
| 04/25/2013 | US20130102585 Azetidinyl diamides as monoacylglycerol lipase inhibitors |
| 04/25/2013 | US20130102576 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors |
| 04/25/2013 | US20130102568 Alkoxyimino derivative and pest control agent |
| 04/25/2013 | US20130102468 6-acyl-1,2,4-triazine-3,5-dione derivative and herbicides |
| 04/25/2013 | US20130101668 Transition metal mediated oxidation of hetero atoms in organic molecules coordinated to transition metals: oxidation of coordinated benzimidazole to omeprazole |
| 04/25/2013 | US20130098770 Plating bath and method |
| 04/25/2013 | CA2853469A1 Compounds that modulate intracellular calcium |
| 04/25/2013 | CA2852750A1 Heteroaryl hydroxamic acid derivatives and their use in the treatment, amelioration or prevention of a viral disease |
| 04/25/2013 | CA2852723A1 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors |
| 04/25/2013 | CA2852425A1 2-pyridyloxy-4-nitrile orexin receptor antagonists |
| 04/25/2013 | CA2852355A1 (hetero)aryl cyclopropylamine compounds as lsd1 inhibitors |
| 04/25/2013 | CA2851589A1 Bicyclic heterocyclic compound |
| 04/25/2013 | CA2850441A1 Solid forms of 1,l-dioxo-4-thiomorpholinyl)-[6-[[3(4-fluorophenyl)-5-methyl-4-isoxazolyl]methoxy]-3-pyridinyl]-methanone |
| 04/24/2013 | EP2583967A1 Crystal of amide compound |